Merck Serono Ventures sees Auxogyn license Stanford research.

Europe's largest venture round of the year doubles to more than $150m the amount raised by Immatics Biotechnologies since its launch.

Venture capital firm TauTona Group seeks strategic partnership after closing $50m fund.

Gedeon Richter will pay up to SFr445m ($462.8m) for PregLem, a biopharmaceutical company focused on the treatment of gynaecological conditions and infertility.

A year after AIG sells venture capital operation Altaris the firm realises part of its Creganna-Tactx Medical stake.

Novartis and Truffle Capital part of consortium in $25.8m C round for Switzerland's Symetis.

Undisclosed healthcare company joins venture consortium investing $46m in IDev Technologies.

Mayo Clinic and the University of Minnesota will try and raise at least $250m to research diabetes and offer corporate venturing opportunities to local companies.

Pacific Biosciences, a US-based gene sequencing company, plans to raise $200m on Nasdaq.

Moksha8, a Brazil-based specialty drugs company, raises $61m in its series D round that includes Watson Pharmaceuticals.